BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8100473)

  • 1. Dynorphin A (1-13) potentiates dynorphin A (1-17) on loss of the tail-flick reflex after intrathecal injection in the rat.
    Qu ZX; Isaac L
    Brain Res; 1993 May; 610(2):340-3. PubMed ID: 8100473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A strychnine-sensitive site is involved in dynorphin-induced paralysis and loss of the tail-flick reflex.
    Stewart P; Isaac L
    Brain Res; 1991 Mar; 543(2):322-6. PubMed ID: 1676332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal dynorphin(1-13) results in an irreversible loss of the tail-flick reflex in rats.
    Caudle RM; Isaac L
    Brain Res; 1987 Dec; 435(1-2):1-6. PubMed ID: 2892573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of the analgesic and paralytic effects induced by intrathecal dynorphin a in rats.
    Xue JC; Yu YX; Han JS; Jen MF
    Int J Neurosci; 1995 May; 82(1-2):83-93. PubMed ID: 7591518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of dynorphin-induced neurotoxicity in rat spinal cord.
    Stewart P; Isaac L
    Life Sci; 1989; 44(20):1505-14. PubMed ID: 2566882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MK-801 blocks dynorphin A (1-13)-induced loss of the tail-flick reflex in the rat.
    Isaac L; Van Zandt O'Malley T; Ristic H; Stewart P
    Brain Res; 1990 Oct; 531(1-2):83-7. PubMed ID: 1981166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
    Long JB; Mobley WC; Holaday JW
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed opioid/nonopioid effects of dynorphin and dynorphin related peptides after their intrathecal injection in rats.
    Przewłocki R; Shearman GT; Herz A
    Neuropeptides; 1983 Jan; 3(3):233-40. PubMed ID: 16229165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dynorphin (1-13) on spinal reflexes in the rat.
    Caudle RM; Isaac L
    J Pharmacol Exp Ther; 1988 Aug; 246(2):508-13. PubMed ID: 2900326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity.
    Stevens CW; Yaksh TL
    J Pharmacol Exp Ther; 1986 Sep; 238(3):833-8. PubMed ID: 2875172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of high intravenous doses of dynorphin A(1-13) on tail flick latency and central nervous system histology in rats.
    Pentel PR; Wananukul W; Hooke LP; Jones CR; Hatsukami D; Anderson WR; Lee NM
    Pharmacol Biochem Behav; 1995; 51(2-3):387-90. PubMed ID: 7667358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecally administered dynorphin-(1-17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant rats.
    Schmauss C; Herz A
    Eur J Pharmacol; 1987 Mar; 135(3):429-31. PubMed ID: 2884124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel interaction between dynorphin(1-13) and an N-methyl-D-aspartate site.
    Caudle RM; Isaac L
    Brain Res; 1988 Mar; 443(1-2):329-32. PubMed ID: 2896056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analgesic effects of dynorphin-A and morphine in mice.
    Nakazawa T; Ikeda M; Kaneko T; Yamatsu K
    Peptides; 1985; 6(1):75-8. PubMed ID: 2859574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of dynorphin A (1-13) and dynorphin A (1-10) amide on stress-induced analgesia.
    Starec M; Rosina J; Málek J; Krsiak M
    Physiol Res; 1996; 45(6):433-8. PubMed ID: 9085373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulators of pain in the spinal cord.
    Jen MF; Lu CH; Huang L; Han JS
    NIDA Res Monogr; 1986; 75():457-60. PubMed ID: 2893278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin-A-(1-13) antagonizes morphine analgesia in the brain and potentiates morphine analgesia in the spinal cord.
    Ren MF; Lu CH; Han JS
    Peptides; 1985; 6(6):1015-20. PubMed ID: 2871545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal kappa receptor-mediated analgesia of E-2078, a systemically active dynorphin analog, in mice.
    Nakazawa T; Furuya Y; Kaneko T; Yamatsu K
    J Pharmacol Exp Ther; 1991 Jan; 256(1):76-81. PubMed ID: 1671100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between motor paralysis and neurotoxicity induced by intrathecal dynorphin A (1-17) in rats].
    Cui CL; Wu LZ; Han JS
    Yao Xue Xue Bao; 1997; 32(2):85-9. PubMed ID: 11243205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal dynorphins suppress hindlimb electromyographic activity in rats.
    Stevens CW; Weinger MB; Yaksh TL
    Eur J Pharmacol; 1987 Jun; 138(2):299-302. PubMed ID: 2887441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.